🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Pilot of Mailing Buprenorphine

RecruitingEARLY Phase 1Ages 18 Years - anyAllMedical University of South Carolina
NCT07421102 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This pilot study evaluates the feasibility, acceptability, and preliminary effectiveness of mailing buprenorphine to individuals with opioid use disorder (OUD) following medical hospitalization. The intervention aims to improve retention in treatment by overcoming barriers such as transportation and pharmacy access.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 18 * English-speaking * Diagnosed with OUD and initiated on buprenorphine during hospitalization * Discharging to a South Carolina address with a stable mailbox * Access to phone or computer Exclusion Criteria: * Active psychosis or suicidal ideation * Severe medical or neurocognitive impairment * Pending incarceration
💊

What it tests

  • strategy of mailing buprenorphine
📍

Where

2 sites
Medical University of South Carolina
Charleston, United States
Medical University of South Carolina
Charleston, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy